医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

腫瘍学

Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

バイオテクノロジーヘルスケア医療機器腫瘍学臨床試験製薬　 TimeLine: Konica Minolta Accelerates Expansion of Precision Through Acquisition of US-based Pharmaceutical

2017年09月25日

0

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone (CS-3150), Including Positive Top-Line Results and Additional Pivotal Study

Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone (CS-3150), Including Positive Top-Line Results and Additional Pivotal Study

バイオテクノロジーヘルスケア心臓学糖尿病腫瘍学臨床試験製薬　 TimeLine: Clinical Progress with Esaxerenone Exelixis Provides Update on Collaborator Daiichi Top-Line Results and Additional Pivotal Study

2017年09月25日

0

Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma

Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma

ヘルスケア腫瘍学製薬　 TimeLine: Approval Shows Sustained Duration of Response of Locally Advanced Basal Cell Carcinoma Sun Pharma Odomzo

2017年09月20日

0

Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited

Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride Ready-to-dilute and Rapid Infusion Injection Products to SymBio Pharmaceuticals Limited

バイオテクノロジーヘルスケア医療用品腫瘍学製薬　 TimeLine: Eagle Pharmaceuticals Licenses Japanese Rights for Hydrochloride Ready-to-dilute and Rapid Infusion SymBio Pharmaceuticals Limited

2017年09月20日

0

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Arcus Biosciences Announces Option and License

2017年09月20日

0

Samsung Bioepis First to Receive Positive CHMP Opinion on a Trastuzumab Biosimilar with ONTRUZANT®

Samsung Bioepis First to Receive Positive CHMP Opinion on a Trastuzumab Biosimilar with ONTRUZANT®

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: Samsung Bioepis First to Receive Positive CHMP Trastuzumab Biosimilar with ONTRUZANT

2017年09月15日

0

H3 Biomedicine to Present New Data on H3B-6527, an FGFR4 Inhibitor, at the 2017 International Liver Cancer Association Annual Meeting

H3 Biomedicine to Present New Data on H3B-6527, an FGFR4 Inhibitor, at the 2017 International Liver Cancer Association Annual Meeting

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬遺伝学　 TimeLine: an FGFR4 Inhibitor at the 2017 International Liver Cancer Association H3 Biomedicine to Present New Data on

2017年09月15日

0

Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Castration-Resistant Prostate Cancer in Patients with Non-Metastatic Pfizer and Astellas Announce Positive Top-Line PROSPER Trial of XTANDI

2017年09月14日

0

Aurigene, a Wholly Owned Subsidiary of Dr. Reddy’s, and Curis Announce CA-170 Program Update Following Data Presented at ESMO 2017

Aurigene, a Wholly Owned Subsidiary of Dr. Reddy’s, and Curis Announce CA-170 Program Update Following Data Presented at ESMO 2017

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: a Wholly Owned Subsidiary of Dr Announce CA-170 Program Update Following Data

2017年09月12日

0

Dr. Reddy’s Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference

Dr. Reddy’s Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference

ヘルスケアヘルス一般糖尿病腫瘍学製薬　 TimeLine: Annual Global Healthcare Conference Reddy's Laboratories Limited to Present at the

2017年09月12日

0